Notices. Notice

252 words·~1 min read·/register/2022/02/01/2022-01949

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA-CE-22-001, Grants To Support New Investigators in Conducting Research Related to Understanding Polydrug Use Risk and Protective Factors; Cancellation of Meeting AGENCY: Centers for Disease Control and Prevention, Department of Health and Human Services. ACTION: Notice. SUPPLEMENTARY INFORMATION:

Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA-CE-22-001, Grants to Support New Investigators in Conducting Research Related to Understanding Polydrug Use Risk and Protective Factors; March 15-16, 2022, 8:30 a.m.-5:30 p.m., EDT. The web conference was published in the **Federal Register** on January 5, 2022, Volume 87, Number 3, page 460. This meeting is being canceled in its entirety.

FOR FURTHER INFORMATION CONTACT: Aisha L. Wilkes, M.P.H., Scientific Review Officer, National Center for Injury Prevention and Control, CDC, 4770 Buford Highway NE, Mailstop S106-9, Atlanta, Georgia 30341-3717, Telephone:

(404)639-6473, Email: *AWilkes@cdc.gov.* The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign **Federal Register** notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2022-01949 Filed 1-31-22; 8:45 am]